Diamorphine

Diamorphine: Overview

Diamorphine is a potent semi-synthetic opioid analgesic derived from morphine that acts as a powerful central nervous system depressant. It is utilized in clinical settings to manage severe, acute, or chronic pain resistant to non-opioid analgesics and to relieve severe dyspnea in acute pulmonary edema.

What Is Diamorphine & How Does It Work?

Diamorphine functions primarily as a lipophilic prodrug for morphine and its active metabolite 6-monoacetylmorphine (6-MAM). Following parenteral administration, its acetyl groups allow Diamorphine to rapidly cross the blood-brain barrier much faster than morphine. Once inside the brain, rapid deacetylation converts Diamorphine into 6-MAM and morphine, which bind as agonists to central and peripheral mu-type opioid receptors. Activation of these mu-opioid receptors stimulates descending inhibitory pain pathways in the central nervous system and blocks nociceptive signal transmission in peripheral sensory neurons, producing profound analgesia, sedation, and relief from severe respiratory distress.

Is Diamorphine FDA Approved?

Diamorphine is not approved by the United States Food and Drug Administration (FDA) and is classified as a Schedule I controlled substance under US federal law. However, Diamorphine is legally approved and routinely utilized as a prescription medication in the United Kingdom and select international jurisdictions. In a Gastroenterology and acute clinical care setting, physicians utilize Diamorphine for palliative pain management in terminally ill patients and emergency analgesia during acute visceral crises.

What Is Diamorphine Used For?

• Relief of severe acute pain associated with major surgical procedures and acute myocardial infarction.
• Palliative control of refractory, severe pain in terminally ill cancer patients.
• Emergency relief of severe breathlessness (dyspnea) caused by acute left ventricular failure and pulmonary edema.

Before Taking Diamorphine: Contraindications & Precautions

Patients must undergo strict clinical evaluation before receiving Diamorphine due to its high potency, rapid onset, and strong potential for physical dependence and respiratory depression.

Who Should Not Take Diamorphine?

Diamorphine is strictly contraindicated in patients with acute severe asthma, paralytic ileus, or severe respiratory depression. It must not be administered to individuals with known hypersensitivity to Diamorphine, morphine, or morphinan alkaloids. Patients with severe liver failure, acute alcoholism, head injuries, or elevated intracranial pressure should strictly avoid this medication.

Diamorphine: Pregnancy & Fertility

Diamorphine crosses the placenta rapidly, and chronic use during pregnancy can cause neonatal opioid withdrawal syndrome, intrauterine growth restriction, or fetal death. It passes into breast milk and can cause respiratory depression and sedation in nursing infants, requiring complete avoidance during lactation. Long-term use of Diamorphine can suppress the hypothalamic-pituitary-gonadal axis, leading to decreased libido, amenorrhea, and impaired human fertility.

Tell Your Doctor Before Taking Diamorphine

Inform your physician if you have a history of chronic obstructive pulmonary disease (COPD), sleep apnea, or severe asthma. Disclose any personal history of substance use disorder, severe kidney dysfunction, or biliary tract disease. Provide a full list of all central nervous system depressants, sedatives, and prescription medications currently being taken.

Diamorphine: Dosage & Administration

Diamorphine is supplied as a sterile powder for solution intended strictly for administration by healthcare professionals via parenteral routes.

• Intravenous Injection: Administered slowly into a vein for immediate pain relief during acute emergencies.
• Subcutaneous or Intramuscular Injection: Injected into subcutaneous tissue or muscle for sustained pain control.
• Subcutaneous Infusion: Administered via continuous syringe driver pumps in palliative end-of-life care settings.

Standard Diamorphine Dosing

For severe acute pain in adults, standard initial parenteral dosing of Diamorphine ranges from 2.5 mg to 5 mg administered intravenously or subcutaneously every four hours as needed. In acute myocardial infarction, a slow intravenous dose of 2.5 mg to 5 mg is typically administered. Dosing in palliative terminal care is carefully titrated individually to achieve complete pain relief without upper dosage ceilings, often utilizing continuous subcutaneous infusions ranging from 10 mg to over 100 mg per 24 hours.

How Diamorphine Is Administered

Diamorphine powder for solution must be reconstituted using sterile water for injection by qualified clinical staff under aseptic conditions. The reconstituted solution is inspected visually for clarity before slow intravenous, intramuscular, or subcutaneous injection.

Diamorphine: Clinical Efficacy & Research

Established clinical consensus confirms that Diamorphine is an exceptionally effective analgesic due to its rapid penetration of central nervous system tissue. Clinical studies demonstrate that its unique lipophilicity allows faster onset of pain relief and higher solubility than morphine, enabling smaller injection volumes for subcutaneous administration in palliative care. Research confirms that when properly titrated in clinical hospital environments, Diamorphine provides rapid relief from severe post-operative pain, cardiac chest pain, and end-of-life dyspnea.

Diamorphine: Side Effects & Safety Profile

Diamorphine produces pronounced, dose-dependent central nervous system and gastrointestinal side effects characteristic of strong mu-opioid agonists.

Common Diamorphine Side Effects

• Severe constipation, nausea, and vomiting
• Drowsiness, sedation, dizziness, and confusion
• Dry mouth, facial flushing, and localized sweating
• Itching (pruritus) and pinpoint pupils (miosis)

Serious Diamorphine Adverse Events

• Life-threatening respiratory depression and hypoventilation
• Severe hypotension, bradycardia, and circulatory collapse
• Paralytic ileus and severe urinary retention
• Psychological dependence, physical addiction, tolerance, and acute withdrawal syndrome

Managing Diamorphine Side Effects

Proactive management of constipation using prophylactic stimulant laxatives and stool softeners is mandatory during Diamorphine therapy. If severe respiratory depression, extreme sedation, or pinpoint pupils develop, immediate administration of an opioid antagonist like naloxone and emergency ventilatory support are required.

Diamorphine: Interactions & What to Avoid

Combining Diamorphine with other central nervous system depressants creates dangerous additive sedation and respiratory depression.

Diamorphine: Interactions

• Central nervous system depressants (benzodiazepines, alcohol, sedatives): Co-administration dramatically increases risks of profound sedation, respiratory depression, coma, and death.
• Monoamine oxidase inhibitors (MAOIs): Combining with MAOIs within 14 days can precipitate severe hypertensive crises or central excitation.
• Anticholinergic medications: Increases the risk of severe urinary retention and paralytic ileus.

Diamorphine: Food & Alcohol

Avoid consuming alcohol under any circumstances while receiving Diamorphine, as alcohol severely exacerbates central respiratory depression and can lead to fatal poisoning. Parenteral administration is independent of food intake, though managing nausea with light meals is helpful.

Diamorphine: Missed Dose, Overdose & Storage

Because Diamorphine is administered by trained clinical staff in controlled hospital environments, dosing errors are strictly managed under hospital protocols.

Missed Dose of Diamorphine

In a clinical setting, missed or delayed doses of Diamorphine should be reported to the attending medical team immediately so pain levels can be reassessed and dosing adjusted.

Diamorphine: Overdose & Emergency

Diamorphine overdose is characterized by the classic triad of pinpoint pupils, marked respiratory depression, and coma. Overdose is a medical emergency requiring immediate airway management, mechanical ventilation, and intravenous administration of the opioid antagonist naloxone.

How To Store Diamorphine

Store Diamorphine powder for solution at controlled room temperature between 15°C and 25°C (59°F and 77°F). Keep vials in their original packaging protected from light, and store them securely inside a locked controlled-substance safe according to local laws.

Diamorphine: Patient Management & Monitoring

Rigorous clinical oversight is required to balance effective pain management against central respiratory depression.

Tests Before Starting Diamorphine

• Baseline respiratory status assessment, including oxygen saturation and blood gas monitoring.
• Baseline liver function and kidney function panels to evaluate metabolite clearance capacity.

Monitoring During Diamorphine Treatment

• Continuous monitoring of respiratory rate, conscious level, blood pressure, and pain scores.
• Regular evaluation for bowel motility, constipation, and signs of opioid tolerance or dependence.

Diamorphine: Do’s and Don’ts

• Do report unmanaged pain or excessive drowsiness to your medical team immediately.
• Do use prescribed laxatives regularly to prevent severe opioid-induced constipation.
• Don’t attempt to drive, operate machinery, or perform hazardous tasks while receiving Diamorphine.
• Don’t stop receiving Diamorphine abruptly after prolonged use to avoid acute withdrawal symptoms.

Frequently Asked Questions

References

• World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index: N07BC06 (Diamorphine).
• DrugBank Online Database. Diamorphine Compound Summary (Accession Number DB01452).

Legal Disclaimer

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.